Status: Recruiting
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
This study is a prospective phase II trial, designed to assess the efficacy and feasibility of adjuvant treatment deintensification guided by ctHPVDNA levels for patients with HPV+OPSCC who undergo transoral surgery and neck dissection.
Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Indiana UniversityUpdated: Jul 31, 2025Locations: 2
Eligibility criteria
Subjects ≥ 18 years old at the time of informed consent. [+11]
Serious medical condition preventing general anesthesia for surgery. [+6]